Aoyagi Yukitoshi, Amamoto Ryuta, Park Sungjin, Honda Yusuke, Shimamoto Kazuhito, Kushiro Akira, Tsuji Hirokazu, Matsumoto Hoshitaka, Shimizu Kensuke, Miyazaki Kouji, Matsubara Satoshi, Shephard Roy J
Exercise Sciences Research Group, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.
Food Research Department, Yakult Central Institute, Tokyo, Japan.
Front Microbiol. 2019 Jul 31;10:1477. doi: 10.3389/fmicb.2019.01477. eCollection 2019.
Infrequent bowel movements decrease the number of beneficial bacteria in the human intestines, thereby potentially increasing the individual's risk of colorectal cancer. The correction of such bowel problems could therefore make an important contribution to improving population health and quality-adjusted lifespan. We examined independent and interactive effects upon the fecal microbiota of two potentially favorable determinants of intestinal motility: the intake frequency of a fermented milk product containing strain Shirota (LcS) and the quantity/quality of habitual physical activity in 338 community-living Japanese aged 65-92 years. Subjects were arbitrarily grouped on the basis of questionnaire estimates of LcS intake (0-2, 3-5, and 6-7 days/week) and pedometer/accelerometer-determined patterns of physical activity [<7000 and ≥7000 steps/day, or <15 and ≥15 min/day of activity at an intensity >3 metabolic equivalents (METs)]. After adjustment for potential confounders, the respective numbers of various beneficial fecal bacteria tended to be larger in more frequent consumers of LcS-containing products, this trend being statistically significant (mostly < 0.001) for total , the subgroup, and the cluster; in contrast, there were no statistically significant differences in fecal bacterial counts between the physical activity groups. A multivariate-adjusted logistic regression analysis estimated that the risk of infrequent bowel movements (arbitrarily defined as defecating ≤3 days/week) was significantly lower ( < 0.05) in subjects who ingested LcS-containing products 6-7 rather than 0-2 days/week [odds ratio (95% confidence interval) 0.382 (0.149-0.974)] and was also lower in those who took ≥7000 rather than <7000 steps/day [0.441 (0.201-0.971)] or spent ≥15 rather than <15 min/day of physical activity at an intensity >3 METs [0.412 (0.183-0.929)]. The risk of infrequent bowel movements in subjects who combined 6-7 days/week of LcS with ≥7000 steps/day or ≥15 min/day of activity at >3 METs was only a tenth of that for individuals who combined 0-2 days/week of LcS with <7000 steps/day or <15 min/day at >3 METs. These results suggest that elderly individuals can usefully ingest LcS-containing supplements regularly (≥6 days/week) and also engage in moderate habitual physical activity (≥7000 steps/day and/or ≥15 min/day at >3 METs) in order to enhance their gastrointestinal health.
排便次数少会减少人体肠道内有益细菌的数量,从而可能增加个体患结直肠癌的风险。因此,纠正此类肠道问题对改善人群健康和质量调整寿命可能会有重要贡献。我们研究了肠道蠕动的两个潜在有利决定因素对粪便微生物群的独立和交互作用:含有嗜热链球菌(LcS)的发酵乳制品的摄入频率,以及338名年龄在65 - 92岁的社区居住日本老年人的习惯性身体活动的量/质。根据对LcS摄入量(0 - 2、3 - 5和6 - 7天/周)的问卷调查估计以及计步器/加速度计确定的身体活动模式[<7000和≥7000步/天,或<15和≥15分钟/天强度>3代谢当量(METs)的活动],将受试者任意分组。在对潜在混杂因素进行调整后,食用含LcS产品更频繁的人群中,各种有益粪便细菌的数量往往更多,对于总双歧杆菌、双歧杆菌亚群和双歧杆菌簇,这种趋势具有统计学意义(大多P<0.001);相比之下,身体活动组之间的粪便细菌计数没有统计学上的显著差异。多变量调整的逻辑回归分析估计,每周摄入含LcS产品6 - 7天而非0 - 2天的受试者,排便次数少(任意定义为每周排便≤3天)的风险显著降低(P<0.05)[优势比(95%置信区间)0.382(0.149 - 0.974)],每天步数≥7000步而非<7000步的受试者风险也较低[0.441(0.201 - 0.971)],或每天进行强度>3 METs的身体活动≥15分钟而非<15分钟的受试者风险也较低[0.412(0.183 - 0.929)]。每周6 - 7天摄入LcS并结合每天≥7000步或每天≥15分钟强度>3 METs活动的受试者,排便次数少的风险仅为每周摄入LcS 0 - 2天并结合每天<7000步或每天<15分钟强度>3 METs活动的个体的十分之一。这些结果表明,老年人可以定期(≥6天/周)有益地摄入含LcS的补充剂,并且进行适度的习惯性身体活动(每天≥7000步和/或每天≥15分钟强度>3 METs),以增强他们的胃肠道健康。